Gabriel Otte
Co-founder, Freenome
- Industry
- Oncology
- Based in
- United States
- Company funding
- $1.1B raised
- Region
- North America
Computational biologist who co-founded a blood based cancer screening company.
Advanced multiomics blood tests for early colorectal cancer detection.
Gabriel Otte is an entrepreneur who studied at Cornell University and developed an interest in both biology and computer science. In 2014 he co-founded Freenome with Riley Ennis, a biotechnology company combining machine learning and biological data to develop blood tests that detect cancer early.
The journey
How Gabriel Otte got here, step by step.
2011
Graduated from Cornell University
Otte graduated from Cornell University, where he studied chemistry and developed software engineering skills.
2012
Software engineering work
He worked as a software engineer, building technical experience that later shaped his approach to biotechnology.
2014
Co-founded Freenome
Otte co-founded Freenome with Riley Ennis to apply machine learning to early cancer detection through blood tests.
2014 to 2020
Built the multiomics platform
Freenome advanced its platform to identify cancer signals in blood samples for earlier diagnosis.
2020s
Expanded clinical studies
Under Otte's leadership Freenome ran large clinical studies to validate its noninvasive screening technology.
2020s
Grew company operations
Freenome expanded its team and operations as it worked towards bringing its screening tests into wider use.